Yahoo Web Search

Search results

1. • 

     Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study

     Zacks via Yahoo Finance· 4 days ago

     However, Bristol Myers’ Revlimid is facing generic competition, which affected its sales in 2023....

2. • Grady County sheriff rings bell amid battle with stage 4 cancer

     KOCO 5 Oklahoma City· 2 days ago

     Grady County Sheriff Gary Boggess has been quietly battling stage four cancer for the past six months. "The biopsy came back, and I had stage four

3. • 

     20 Countries with the Highest Cancer Survival Rates in the World

     Insider Monkey via Yahoo Finance· 3 hours ago

     In this article, we will be taking a look at the 20 countries with the highest cancer survival rates...

4. • 

     Weedkiller manufacturer seeks lawmakers' help to squelch claims it failed to warn about cancer

     Stamford Advocate· 4 days ago

     Nearly identical bills introduced in Iowa, Missouri and Idaho this year — with wording supplied by...

5. • Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update

     ETF DAILY NEWS· 6 days ago

     Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 7,690,000 shares, an ...

6. • Cancer Is Predicted to Rise by 77% in 2050

     Mercola· 3 days ago

     The World Health Organization’s International Agency for Research on Cancer (IARC) released a daunting prediction of the global cancer burden. While WHO named an aging population ...

7. • C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Consensus Rating of “Moderate Buy” from Brokerages

     ETF DAILY NEWS· 6 days ago

     Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the company, Marketbeat reports ...

8. • Vanguard Group Inc. Increases Stock Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU)

     ETF DAILY NEWS· 5 days ago

     Vanguard Group Inc. grew its holdings in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) by 49.3% in the 3rd quarter, according to its most recent 13F filing with the Securities ...

9. • Nkarta (NASDAQ:NKTX) Earns “Buy” Rating from Needham & Company LLC

     ETF DAILY NEWS· 7 days ago

     Needham & Company LLC reaffirmed their buy rating on shares of Nkarta (NASDAQ:NKTX – Free Report) in a research note released on Wednesday, Benzinga reports. Needham & Company LLC currently ...